News | September 22, 2011

HFSA Session Highlights Growing Relationship Between Cardiology and Oncology

September 22, 2011 — The 15th annual scientific meeting of the Heart Failure Society of America (HFSA) will feature a session titled "Cancer Chemotherapy and Cardiotoxicity" moderated by Daniel J. Lenihan, M.D., professor of medicine at Vanderbilt University. It will focus on the effect of cancer drugs on the presence of heart failure and how oncologists and cardiologists have developed close collaboration in order to benefit patients.

Scheduled presentations include discussions of long-term cancer care and its relation to cardiology; effects of chemotherapy on cardiotoxicity; and the effect of heart failure on therapies for cancer patients. The session highlights how physicians should treat patients and collaborate with other doctors in different areas.

"It's no longer a physician's myopic perspective when caring for a patient; we're all on the same team – the patient's team," said Lenihan. "As cardiologists engage more and more with oncologists, and vice-versa, we are not only benefiting our current patients but are also enhancing the future of modern medicine."

The session will describe the impact of chemotherapeutic agents on heart failure and will discuss recommended management options. Doctors will also discuss recent research and discoveries relating to heart failure and its connection to cancer chemotherapy.

For more information: www.hfsa.org

Related Content

Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Heart Attack, Stroke Risks Increase Leading Up to Cancer Diagnosis
News | Cardio-oncology | December 21, 2018
Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer...
Xarelto Reduces Blood Clot Events in High-Risk Cancer Patients
News | Cardio-oncology | December 07, 2018
New data from the Phase 3 CASSINI study showed a 60 percent reduction of venous thromboembolism (VTE, or blood clot)...
Beta Blocker Shows Mixed Results in Protecting Against Chemo-Induced Heart Damage
News | Cardio-oncology | March 14, 2018
After six months of follow-up, women newly diagnosed with breast cancer who were given the beta blocker carvedilol to...
Heart Failure More Likely for Some Breast Cancer and Lymphoma Survivors
News | Cardio-oncology | March 01, 2018
March 1, 2018 –  Patients who were treated for breast cancer or lymphoma are more than three times at risk for develo
Cell phone emissions cause cardiac tumors in males rats.
News | Cardio-oncology | February 06, 2018
High exposure to radiofrequency radiation (RFR) in rodents resulted in tumors in tissues surrounding nerves in the...
Videos | Cardio-oncology | February 01, 2018
American Heart Association (AHA) released a scientific statement Feb.
Overlay Init